An Apoptosis Methylation Prognostic Signature for Early Lung Cancer in the IFCT-0002 Trial

相似书籍

• MSH2/BRCA1 expression as a DNA-repair signature predicting survival in early–stage lung cancer patients from the IFCT-0002 Phase 3 Trial
  由: Levallet, Guénaëlle, et al.
  出版: (2016)
• High TUBB3 Expression, an Independent Prognostic Marker in Patients with Early Non–Small Cell Lung Cancer Treated by Preoperative Chemotherapy, Is Regulated by K-Ras Signaling Pathway
  由: Guénaëlle Levallet, et al.
  出版: (2012)
• Role of the YAP-1 Transcriptional Target cIAP2 in the Differential Susceptibility to Chemotherapy of Non-Small-Cell Lung Cancer (NSCLC) Patients with Tumor RASSF1A Gene Methylation from the Phase 3 IFCT-0002 Trial
  由: Dubois, Fatéméh, et al.
  出版: (2019)
• MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial
  由: Maille, Elodie, et al.
  出版: (2019)
• Pathologic Complete Response to Preoperative Chemotherapy Predicts Cure in Early-Stage Non–Small-Cell Lung Cancer: Combined Analysis of Two IFCT Randomized Trials
  由: Guillaume Mouillet, et al.
  出版: (2012)